Home
Vista Pharmaceuticals Ltd Board of Directors
Board of Directors at Vista Pharmaceuticals Ltd
Company Sec. & Compli. Officer
Non-Exec. & Independent Dir.
Chairman & Wholetime Director
Director
Non-Exec. & Independent Dir.
Key Highlights
- Dhananjaya Alli continues to serve as the Chairman & Wholetime Director in 2024, maintaining the same position as in the previous year.
- M H Rao continues to serve as the Non-Exec & Non-Independent Dir in 2024, maintaining the same position as in the previous year.
- Stanley Prabhakar Reddy continues to serve as the Non-Exec & Non-Independent Dir in 2024, maintaining the same position as in the previous year.
- Umesh V Banakar continues to serve as the Non-Exec. & Independent Dir. in 2024, maintaining the same position as in the previous year.
- Chakravarthula Divya Bhavani joins the board as Non-Exec. & Independent Dir., in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.

Vista Pharmaceuticals Ltd
NSE: VISTAPHARMA
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 11.25 |
20 Feb 2025 | 10.98 |
19 Feb 2025 | 10.6 |
18 Feb 2025 | 10.7 |
17 Feb 2025 | 10.82 |
14 Feb 2025 | 11.15 |
13 Feb 2025 | 10.9 |
12 Feb 2025 | 10.7 |
11 Feb 2025 | 10.78 |
10 Feb 2025 | 10.84 |
Company Fundamentals for Vista Pharmaceuticals Ltd
Market Cap
43 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
1.0
Day’s High
11.25
Day’s Low
10.51
DTE
0.1
ROE
-7.0
52 Week High
16.59
52 Week Low
9.1
ROCE
-6.6
Market Price of Vista Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Vista Pharmaceuticals Ltd News Hub
Vista Pharmaceuticals reports standalone net loss of Rs 0.86 crore in the June 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as agains
Read more
14 Aug 24
Vista Pharmaceuticals to discuss results
Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
06 Aug 24
Vista Pharmaceuticals to conduct AGM
Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company will be he
Read more
10 Sept 24
Vista Pharmaceuticals reports standalone net loss of Rs 0.97 crore in the September 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.97 crore in the quarter ended September 2024 as a
Read more
14 Nov 24